Prospective comparison of subcutaneous to intravenous administration of bortezomib in patients with multiple myeloma: Pharmacokinetics, efficacy and toxicity

被引：0
作者：
Moreau, P.
Coiteux, V.
Hulin, C.
Facon, T.
van de Velde, H.
Acharya, M.
Harousseau, J.
机构：
[1] CHU Hotel Dieu, Nantes, France
[2] Univ Hosp, Lille, France
[3] Univ Hosp, Nancy, France
[4] Johnson & Jonhson, R&D, Beerse, Belgium
[5] Johnson & Jonhson, R&D, Raritan, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients
    Jung, Joo Young
    Kim, Ho Young
    Han, Boram
    Choi, Dae Ro
    Zang, Dae Young
    Kim, Hyo Jung
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [42] Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers
    Soefje, Scott A.
    Carpenter, Corinne
    Carlson, Katherine
    Awasthi, Samir
    Lin, Thomas S.
    Kaila, Shuchita
    Tarjan, Daniel
    Kayal, Nikhil
    Kirkup, Christian
    Wagner, Tyler E.
    Gray, Kathleen S.
    Kumar, Shaji
    [J]. JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 208 - +
  • [43] Comparison of the pharmacokinetics of subcutaneous and intravenous administration of a phosphorothioate oligodeoxynucleotide in cynomolgus monkeys
    Leeds, JM
    Henry, SP
    Geary, R
    Burckin, T
    Levin, AA
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (06): : 435 - 441
  • [44] BLOOD DISTRIBUTION OF SUBCUTANEOUS BORTEZOMIB AND ITS KINETICS IN MULTIPLE MYELOMA PATIENTS
    Osawa, Takashi
    Naito, Takafumi
    Mino, Yasuaki
    Kawakami, Junichi
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S89 - S89
  • [45] Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses
    Chiavaccini, L.
    Claude, A. K.
    Lee, J. H.
    Ross, M. K.
    Meyer, R. E.
    Langston, V. C.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 (04) : 365 - 374
  • [46] An evaluation of efficiency, safety, tolerability, patient satisfaction, and preference of subcutaneous (SQ) versus intravenous (IV) bortezomib (BTZ) administration in patients with multiple myeloma (MM).
    Barbee, Meagan Spencer
    Wilson, Nicole Maire
    Harvey, R. Donald
    McKibbin, Trevor
    Lonial, Sagar
    Kaufman, Jonathan L.
    Shah, Katherine Sanvidge
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] A PHARMACOKINETICS CLINICAL STUDY OF BORTEZOMIB SUBCUTANEOUS INJECTION VERSUS INTRAVENOUS INJECTION COMBINED WITH CHEMOTHERAPY IN CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA-INTERIM RESULTS
    Fu, C.
    Wu, D.
    Zhu, X.
    Jin, S.
    Yan, L.
    Yan, S.
    Wang, P.
    Ge, Y.
    Chang, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 794 - 794
  • [48] Phase Ib Study Investigating the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Administration of ABBV-383 in Patients With Relapsed/Refractory Multiple Myeloma
    Gatt, Moshe
    Magen, Hila
    McKay, John
    Karlin, Lionel
    Touzeau, Cyrille
    Vincent, Laure
    Kapoor, Prashant
    Leleu, Xavier
    Uchida, Toshiki
    Weisel, Katja
    Bueno, Orlando
    Rosenberg, Tanya
    Ahsan, Aarif
    Jin, Ziyi
    Polepally, Akshanth
    Talati, Chetasi
    Pothacamury, Rajvineeth
    Chhabra, Saurabh
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S54 - S55
  • [49] Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma
    Arnulf, Bertrand
    Pylypenko, Halyna
    Groslcki, Sebastian
    Karamanesht, Ievgenii
    Leleu, Xavier
    van de Velde, Helgi
    Feng, Huaibao
    Cakana, Andrew
    Deraedt, William
    Moreau, Philippe
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (12): : 1925 - 1928
  • [50] COMPARATIVE EFFICIENCY OF SUBCUTANEOUS AND INTRAVENOUS BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: SUMMING UP THE RECORDS OF MUNICIPAL HEMATOLOGICAL CENTER, NOVOSIBIRSK
    Pospelova, T., I
    Skvortsova, N., V
    Nechunaeva, I. N.
    Tairova, S. A.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (02): : 15 - 20
12345